Factor XI deficiency in Southern Iran: Identification of a novel missense mutation

Mehran Karimi, Hamta Jafari, Saba Lahsaeizadeh, Abdolreza Afrasiabi, Ahmad Akbari, Javad Dehbozorgian, Rezvan Ardeshiri, Ilaria Guella, Rosanna Asselta, Flora Peyvandi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Factor XI (FXI)-deficiency is a rare coagulation disorder inherited as an autosomal recessive trait, which is most common in Ashkenazi Jews, but also found in other groups like Moslems. We have reviewed for the first time cases of FXI deficiency in southern Iran in order to analyze their mutations related to factor XI, the main clinical and biological features, levels of circulating factor XI, and bleeding history. All 15 exons and exon-intron boundaries of F11 were polymerase chain reaction amplified using sets of primers designed on the basis of the known genomic sequence of the gene. Among bleeding disorder cases, five were FXI-deficient. FXI clotting activity ranged 0.39-16%. All were severely deficient. In all analyzed patients, functional level of FXI was markedly reduced, confirming the diagnosis of quantitative FXI deficiency. Sequencing of F11 identified three mutations: (1) a highly prevalent type II nonsense mutation (Glu117stop) in a homozygous patient, (2) a previously reported missense (Glu547Lys), and (3) novel missense (Gly372Ala) mutation. No causative mutation was found in the sequenced regions of other patients. One novel mutation and two previously described mutations were identified in patients living in southern Iran. No recurrent mutation was found, perhaps because there is a more intense population mixing in southern Iran. Screening a higher number of FXI-deficient patients will also be necessary to reveal the existence of a founder effect for these mutations in the Iranian population.

Original languageEnglish
Pages (from-to)359-363
Number of pages5
JournalAnnals of Hematology
Volume88
Issue number4
DOIs
Publication statusPublished - 2009

Fingerprint

Factor XI Deficiency
Factor XI
Missense Mutation
Iran
Mutation
Exons
Inherited Blood Coagulation Disorders
Hemorrhage
Founder Effect
Jews
Nonsense Codon
Introns
Population
Polymerase Chain Reaction

Keywords

  • Deficiency
  • Factor XI
  • Missense
  • Mutation
  • Southern Iran

ASJC Scopus subject areas

  • Hematology

Cite this

Karimi, M., Jafari, H., Lahsaeizadeh, S., Afrasiabi, A., Akbari, A., Dehbozorgian, J., ... Peyvandi, F. (2009). Factor XI deficiency in Southern Iran: Identification of a novel missense mutation. Annals of Hematology, 88(4), 359-363. https://doi.org/10.1007/s00277-008-0595-4

Factor XI deficiency in Southern Iran : Identification of a novel missense mutation. / Karimi, Mehran; Jafari, Hamta; Lahsaeizadeh, Saba; Afrasiabi, Abdolreza; Akbari, Ahmad; Dehbozorgian, Javad; Ardeshiri, Rezvan; Guella, Ilaria; Asselta, Rosanna; Peyvandi, Flora.

In: Annals of Hematology, Vol. 88, No. 4, 2009, p. 359-363.

Research output: Contribution to journalArticle

Karimi, M, Jafari, H, Lahsaeizadeh, S, Afrasiabi, A, Akbari, A, Dehbozorgian, J, Ardeshiri, R, Guella, I, Asselta, R & Peyvandi, F 2009, 'Factor XI deficiency in Southern Iran: Identification of a novel missense mutation', Annals of Hematology, vol. 88, no. 4, pp. 359-363. https://doi.org/10.1007/s00277-008-0595-4
Karimi M, Jafari H, Lahsaeizadeh S, Afrasiabi A, Akbari A, Dehbozorgian J et al. Factor XI deficiency in Southern Iran: Identification of a novel missense mutation. Annals of Hematology. 2009;88(4):359-363. https://doi.org/10.1007/s00277-008-0595-4
Karimi, Mehran ; Jafari, Hamta ; Lahsaeizadeh, Saba ; Afrasiabi, Abdolreza ; Akbari, Ahmad ; Dehbozorgian, Javad ; Ardeshiri, Rezvan ; Guella, Ilaria ; Asselta, Rosanna ; Peyvandi, Flora. / Factor XI deficiency in Southern Iran : Identification of a novel missense mutation. In: Annals of Hematology. 2009 ; Vol. 88, No. 4. pp. 359-363.
@article{490c42d63c68400aae54a9348b1153c6,
title = "Factor XI deficiency in Southern Iran: Identification of a novel missense mutation",
abstract = "Factor XI (FXI)-deficiency is a rare coagulation disorder inherited as an autosomal recessive trait, which is most common in Ashkenazi Jews, but also found in other groups like Moslems. We have reviewed for the first time cases of FXI deficiency in southern Iran in order to analyze their mutations related to factor XI, the main clinical and biological features, levels of circulating factor XI, and bleeding history. All 15 exons and exon-intron boundaries of F11 were polymerase chain reaction amplified using sets of primers designed on the basis of the known genomic sequence of the gene. Among bleeding disorder cases, five were FXI-deficient. FXI clotting activity ranged 0.39-16{\%}. All were severely deficient. In all analyzed patients, functional level of FXI was markedly reduced, confirming the diagnosis of quantitative FXI deficiency. Sequencing of F11 identified three mutations: (1) a highly prevalent type II nonsense mutation (Glu117stop) in a homozygous patient, (2) a previously reported missense (Glu547Lys), and (3) novel missense (Gly372Ala) mutation. No causative mutation was found in the sequenced regions of other patients. One novel mutation and two previously described mutations were identified in patients living in southern Iran. No recurrent mutation was found, perhaps because there is a more intense population mixing in southern Iran. Screening a higher number of FXI-deficient patients will also be necessary to reveal the existence of a founder effect for these mutations in the Iranian population.",
keywords = "Deficiency, Factor XI, Missense, Mutation, Southern Iran",
author = "Mehran Karimi and Hamta Jafari and Saba Lahsaeizadeh and Abdolreza Afrasiabi and Ahmad Akbari and Javad Dehbozorgian and Rezvan Ardeshiri and Ilaria Guella and Rosanna Asselta and Flora Peyvandi",
year = "2009",
doi = "10.1007/s00277-008-0595-4",
language = "English",
volume = "88",
pages = "359--363",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Factor XI deficiency in Southern Iran

T2 - Identification of a novel missense mutation

AU - Karimi, Mehran

AU - Jafari, Hamta

AU - Lahsaeizadeh, Saba

AU - Afrasiabi, Abdolreza

AU - Akbari, Ahmad

AU - Dehbozorgian, Javad

AU - Ardeshiri, Rezvan

AU - Guella, Ilaria

AU - Asselta, Rosanna

AU - Peyvandi, Flora

PY - 2009

Y1 - 2009

N2 - Factor XI (FXI)-deficiency is a rare coagulation disorder inherited as an autosomal recessive trait, which is most common in Ashkenazi Jews, but also found in other groups like Moslems. We have reviewed for the first time cases of FXI deficiency in southern Iran in order to analyze their mutations related to factor XI, the main clinical and biological features, levels of circulating factor XI, and bleeding history. All 15 exons and exon-intron boundaries of F11 were polymerase chain reaction amplified using sets of primers designed on the basis of the known genomic sequence of the gene. Among bleeding disorder cases, five were FXI-deficient. FXI clotting activity ranged 0.39-16%. All were severely deficient. In all analyzed patients, functional level of FXI was markedly reduced, confirming the diagnosis of quantitative FXI deficiency. Sequencing of F11 identified three mutations: (1) a highly prevalent type II nonsense mutation (Glu117stop) in a homozygous patient, (2) a previously reported missense (Glu547Lys), and (3) novel missense (Gly372Ala) mutation. No causative mutation was found in the sequenced regions of other patients. One novel mutation and two previously described mutations were identified in patients living in southern Iran. No recurrent mutation was found, perhaps because there is a more intense population mixing in southern Iran. Screening a higher number of FXI-deficient patients will also be necessary to reveal the existence of a founder effect for these mutations in the Iranian population.

AB - Factor XI (FXI)-deficiency is a rare coagulation disorder inherited as an autosomal recessive trait, which is most common in Ashkenazi Jews, but also found in other groups like Moslems. We have reviewed for the first time cases of FXI deficiency in southern Iran in order to analyze their mutations related to factor XI, the main clinical and biological features, levels of circulating factor XI, and bleeding history. All 15 exons and exon-intron boundaries of F11 were polymerase chain reaction amplified using sets of primers designed on the basis of the known genomic sequence of the gene. Among bleeding disorder cases, five were FXI-deficient. FXI clotting activity ranged 0.39-16%. All were severely deficient. In all analyzed patients, functional level of FXI was markedly reduced, confirming the diagnosis of quantitative FXI deficiency. Sequencing of F11 identified three mutations: (1) a highly prevalent type II nonsense mutation (Glu117stop) in a homozygous patient, (2) a previously reported missense (Glu547Lys), and (3) novel missense (Gly372Ala) mutation. No causative mutation was found in the sequenced regions of other patients. One novel mutation and two previously described mutations were identified in patients living in southern Iran. No recurrent mutation was found, perhaps because there is a more intense population mixing in southern Iran. Screening a higher number of FXI-deficient patients will also be necessary to reveal the existence of a founder effect for these mutations in the Iranian population.

KW - Deficiency

KW - Factor XI

KW - Missense

KW - Mutation

KW - Southern Iran

UR - http://www.scopus.com/inward/record.url?scp=60749120844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60749120844&partnerID=8YFLogxK

U2 - 10.1007/s00277-008-0595-4

DO - 10.1007/s00277-008-0595-4

M3 - Article

C2 - 18758779

AN - SCOPUS:60749120844

VL - 88

SP - 359

EP - 363

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 4

ER -